{"news_desk": "Business", "print_page": "9", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "New type of drug for Alzheimer's disease, called LMTX, fails to slow rate of decline in mental ability and daily functioning in its first large clinical trial; treatment, developed by TauRx Therapeutics, shows efficacy for fraction of patients, however. ", "type_of_material": "News", "word_count": "1132", "lead_paragraph": "The drug did work on a handful of patients taking it alone, without another medication. But some experts were skeptical about the small subset.", "pub_date": "2016-07-27T12:01:54+0000", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Alzheimer\u2019s Drug LMTX Falters in Final Stage of Trials", "print_headline": "Alzheimer\u2019s Drug, Full of Promise, Falters in the Final Stage of Trials"}, "snippet": "The drug did work on a handful of patients taking it alone, without another medication. But some experts were skeptical about the small subset....", "multimedia": [{"height": 126, "url": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 382, "url": "images/2016/07/28/business/28BRAIN/28BRAIN-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "382", "xlarge": "images/2016/07/28/business/28BRAIN/28BRAIN-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/07/28/business/alzheimers-drug-lmtx-trial.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Alzheimer's Disease", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "TauRx Pharmaceuticals Ltd", "name": "organizations"}], "blog": [], "_id": "5798a2b638f0d86000922a65", "source": "The New York Times"}